Background Although the risk of human papillomavirus (HPV) infection is greatest in young
women, women older than 25 years remain at risk. We present data from the VIVIANE study …

We evaluated the efficacy of the human papillomavirus (HPV)− 16/18 AS04‐adjuvanted
vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc …

Whereas safety and efficacy of HPV vaccines in healthy women have been shown in several
randomised controlled clinical trials and in post marketing analyses, only few data exist in …

INTRODUCTION—Human papillomavirus (HPV) is a sexually transmitted pathogen that
causes anogenital and oropharyngeal disease in males and females. Persistent viral …

School-based, free HPV vaccination for girls in the first year of secondary school was
introduced in Flanders (Belgium) in 2010. Before that, non school-based, co-payment …

Human papillomaviruses (HPVs) are aetiologically linked to the development of various
benign and malignant lesions of the skin and mucosa [1–4]. The current theme issue …

Background. Expanding routine human papillomavirus (HPV) vaccination to adults could be
an effective strategy to improve prevention of HPV infection and cervical cancer. Methods …

OBJETIVO: Determinar la asociación entre los márgenes afectados con la persistencia-
recurrencia de neoplasia intraepitelial cervical, persistencia del virus del papiloma humano …

Introduction: Cervix cancer is the fourth most common female cancer and the second most
frequent in women aged 15 to 44 years. The infection by the human papillomavirus is a …

Objective: To determine the association between affected margins with
persistencerecurrence of cervical intraepithelial neoplasia, persistence of human …